2021. The effectiveness of new hormone therapy treatments on progression-free survival of patients with HR+/HER2- metastatic breast cancer: a systematic review. Research, Society and Development. 10, 14 (Oct. 2021), e85101421940. DOI:https://doi.org/10.33448/rsd-v10i14.21940.